NPPB and bronchopulmonary dysplasia: Since biomarkers may prove useful in guiding BPD-PH therapy, we determined serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels as a secondary outcome measure in ELGANs up to 12 months of chronological age.